Agar dilution and disk diffusion susceptibility testing of Campylobacter spp. [5]

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2758-2759

  Fritsche, Thomas R ^a   McDermott, Patrick F ^b   Shryock, Thomas R ^c   Walker, Robert D ^d  

^a JMI LABORATORIES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ELANCO ANIMAL HEALTH   (United States)

^d and Mass Communication   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; TETRACYCLINE;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; CAMPYLOBACTER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION; DILUTION; DISK DIFFUSION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

CAMPYLOBACTER;

EID: 34548056737     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00569-07     Document Type: Letter

References (10)

1. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Luangtongkum, T., T. Y. Morishita, A. B. El-Tayeb, A. J. Ison, and Q. Zhang. 2007. Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods. J. Clin. Microbiol. 45:590-594.
4. McDermott, P. F., S. M. Bodeis, F. M. Aarestrup, S. Brown, M. Traczewski, P. Fedorka-Cray, M. Wallace, I. A. Critchley, C. Thornsberry, S. Graff, R. Flamm, J. Beyer, D. Shortridge, L. J. Piddock, V. Ricci, M. M. Johnson, R. N. Jones, B. Reller, S. Mirrett, J. Aldrobi, R. Rennie, C. Brosnikoff, L. Turnbull, G. Stein, S. Schooley, R. A. Hanson, and R. D. Walker. 2004. Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb. Drug Resist. 10:124-131.
5. McDermott, P. F., S. M. Bodeis-Jones, T. R. Fritsche, R. N. Jones, R. D. Walker, and the Campylobacter Susceptibility Testing Group. 2005. Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents. J. Clin. Microbiol. 43:6136-6138.
6. National Committee for Clinical Laboratory Standards. 2001. Development of in vitro susceptibility testing criteria and quality controls parameters; approved guideline, 2nd ed. M23-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
7. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
8. National Committee for Clinical Laboratory Standards. 2002. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents; approved guideline, 2nd ed. M37-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; informational supplement. M31-S1. National Committee for Clinical Laboratory Standards, Wayne, PA.
10. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; 12th informational supplement. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA.